A peripheral injection of oxytocin can also activate hypothalamic oxytocin neurons to exert metabolic effects, providing a potential clinical avenue for obesity control in mice [197]. The gene discussed is OXT; the disease is obesity due to melanocortin 4 receptor deficiency.